OncoMethylome Sciences was established by a management staff with extensive biotechnology industry experience.
Herman Spolders, Chief Executive Officer
Mr. Spolders founded OncoMethylome Sciences in January 2003 and has had more than 30 years experience in the biotechnology industry in Europe and the USA with Organon Teknika (Akzo Nobel), Tibotec-Virco, Devgen, and IGEN International.
Joseph Bigley, M.Sc., VP Clinical Development
Mr. Bigley is co-founder of OncoMethylome Sciences and has more than 25 years of industry experience including clinical research and development positions within Tibotec-Virco, Burroughs Wellcome, Glaxo Wellcome and Hoffmann-La Roche.
Philip Devine, MBA, CPA, Chief Financial Officer
Mr. Devine is co-founder of OncoMethylome Sciences. Prior to joining OncoMethylome Mr. Devine served as CFO of Tibotec-Virco, as a manager at consulting firm McKinsey & Company, and as an auditor with Deloitte & Touche.
Harry Schrickx, VP Business Development and Marketing
Mr. Schrickx joined OncoMethylome Sciences on May 2003 with 22 years experience in the biotech industry at Organon Teknika (AKZONOBEL) and bioMerieux.
James DiGuiseppi, Ph.D., Chief Technology Officer
Dr. DiGuiseppi has over 15 years of biotechnology experience and has held several senior scientific and managerial posts with Organon Teknica and bioMerieux.
Katja Bierau, Ph.D., VP Laboratory Operations
Dr. Bierau joined OncoMethylome form PamGene International in the Netherlands where she was leader pf ADMET. Dr. Bierau holds a PhD in cancer studies from Birmingham University (U.K.).
Wim Van Criekinge, Ph.D., prof., VP Biomarker and Pharmacogenomics Research
Prof. Van Criekinge is a leading specialist in bioinformatics. He was formerly a co-founder of Devgen and is currently part-time professor of computational genomics and bioinformatics at the molecular biotechnology department of the University of Ghent.
Joost Louwagie, Ph.D., VP, Product Development
Dr. Louwagie joined OncoMethylome after ten years of experience at Innogenetics where he was group manager of diagnostic research and development activities. Dr. Louwagie holds a PhD in Biochemistry from the University of Leuven (Belgium).
Luc Segers, Senior Director Business Development
Mr. Segers joined OncoMethylome after 15 years of experience at Innogenetics, where he held senior management positions in sales and marketing. Mr. Segers holds a Master degree in Biochemical engineering from Antwerp University.
Joseph Sollee, J.D., LLM, Group General Counsel
Mr. Sollee has provided legal counsel to OncoMethylome Sciences since its inception in 2003, and in April 2008 joined our management team as Group General Counsel. Mr. Sollee received a Juris Doctorate in Law and a Masters degree in International Law from Duke University, a BA degree from Harvard University, and has been awarded New York, Washington D.C. and North Carolina legal bar certifications.
Gert-Jan Renardel de Lavalette, Chief Operations Officer
Prior to joining OncoMethylome in the beginning of 2009, Mr. Renardel de Lavalette held several management functions in the group of Pharma Companies of Akzo Nobel, both in diagnostics and pharmaceuticals, including General Management positions in several countries.